| Views | |
|---|---|
| Molecular docking, ADMET study and in vivo pharmacological research of N-(3,4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl]thio}acetamide as a promising anticonvulsant | 148 |
| December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|---|
| Molecular docking, ADMET study and in vivo pharmacological research of N-(3,4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl]thio}acetamide as a promising anticonvulsant | 5 | 2 | 0 | 5 | 4 | 4 | 0 |
| Views | |
|---|---|
| Severina_Molecular_20.pdf | 94 |
| Views | |
|---|---|
| United States | 41 |
| Canada | 22 |
| China | 8 |
| Germany | 6 |
| Japan | 5 |
| Vietnam | 5 |
| Australia | 3 |
| Argentina | 2 |
| Brazil | 2 |
| Turkey | 2 |
| Views | |
|---|---|
| Ottawa | 22 |
| Mountain View | 9 |
| Shenzhen | 7 |
| Houston | 5 |
| Dearborn | 4 |
| Fairfield | 3 |
| Hanoi | 3 |
| Kanda | 3 |
| Baltimore | 2 |
| Kiev | 2 |